~~<i id='3C4228C21D'><strike id='3C4228C21D'><tt id='3C4228C21D'><pre id='3C4228C21D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

explore

author：knowledge 2025-09-29 16:44:44 - browse：5171

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Health AI: on the border between health care and tech

Wikipedia

hotspot

explore

hotspot

entertainment

EliLillyDavidRicksisabigearlydonortoasuperPACsupportingMikePence.CarolynKaster/APWASHINGTON—DavidRic

WSS

Illinois Supreme Court finds assault weapons ban constitutional

House panel takes first step toward fixing drug shortages

Grad students accuse University of California of wage theft

YouTube cracks down on misinformation on cancer treatment

Free Covid tests will again be offered to all U.S. households

Hospitals are dialing back on venture capital investing

Wikipedia

explore

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Patients, digital health players weigh in on FTC's data privacy plan

New air purifier tech could be key to improving indoor air quality

Patients, doctors press FTC to beef up hospital merger scrutiny

Apple is now the first public company to be valued at $3 trillion

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Information blocking fines are now fair game in health care

BioMarin wins approval for gene therapy to treat hemophilia A

Mark Cuban is blaming the wrong people for high drug costs

hotspot

Patients, digital health players weigh in on FTC's data privacy plan

David Liu startup to focus on CRISPR delivery

The struggle to figure out which patients 'deserve' Wegovy

Why the drug industry's warnings on the IRA's impact fall short

Biden administration begins canceling student loan debt for 804,000 borrowers

Hospitals are dialing back on venture capital investing

explore

hotspot

entertainment

entertainment